ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT

Huang, Xiaomei; Mai, Jinhai; Huang, Yanqi; He, Lan; Chen, Xin; Wu, Xiaomei; Li, Yexing; Yang, Xiaojun; Dong, Mengyi; Huang, Jia; Zhang, Fang; Liang, Changhong*; Liu, Zaiyi*广东省人民医院; 南方医科大学; 1
Clinical Breast Cancer2021-8DOI: 10.1016/j.clbc.2020.12.004
9被引6阅读
引用收藏
分享

摘要

This study retrospectively analyzed 215 patients to develop and validate a radiomic nomogram based on staging contrast-enhanced computed tomography for pretreatment prediction of pathologic complete response to neoadjuvant therapy in breast cancer. With an area under the curve of 0.818, the radiomic nomogram could serve as a complementary tool for pretreatment individualized prediction of therapeutic effect to assist clinical decision-making and improve patient outcome. @@@ Introduction: The purpose of this study was to predict pathologic complete response (pCR) to neoadjuvant therapy in breast cancer using radiomics based on pretreatment staging contrast-enhanced computed tomography (CECT). Patients and Methods: A total of 215 patients were retrospectively analyzed. Based on the intratumoral and peritumoral regions of CECT images, radiomic features were extracted and selected, respectively, to develop an intratumoral signature and a peritumoral signature with logistic regression in a training dataset (138 patients from November 2015 to October 2017). We also developed a clinical model with the molecular characterization of the tumor. A radiomic nomogram was further constructed by incorporating the intratumoral and peritumoral signatures with molecular characterization. The performance of the nomogram was validated in terms of discrimination, calibration, and clinical utility in an independent validation dataset (77 patients from November 2017 to December 2018). Stratified analysis was performed to develop a subtype-specific radiomic signature for each subgroup. Results: Compared with the clinical model (area under the curve [AUC], 0.756), the radiomic nomogram (AUC, 0.818) achieved better performance for pCR prediction in the validation dataset with continuous net reclassification improvement of 0.787 and good calibration. Decision curve analysis suggested the nomogram was clinically useful. Subtype-specific radiomic signatures showed improved AUCs (luminal subgroup, 0.936; human epidermal growth factor receptor 2-positive subgroup, 0.825; and triple negative subgroup, 0.858) for pCR prediction. Conclusion: This study has revealed a predictive value of pretreatment staging-CECT and successfully developed and validated a radiomic nomogram for individualized prediction of pCR to neoadjuvant therapy in breast cancer, which could assist clinical decision-making and improve patient outcome.

学科与关键词

关键词
Breast neoplasmChemotherapyMedical image analysisTomographyX-ray computed
相关
加载中…
  • Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer
    Zeng, Qiao; Xiong, Fei; Liu, Lan; Zhong, Linhua; Cai, Fengqin; Zeng, Xianjun*ACADEMIC RADIOLOGY, 2023, 30 Suppl 2: S38-S49.
  • PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer
    Yang, Liping; Chang, Jianfei; He, Xitao; Peng, Mengye; Zhang, Ying; Wu, Tingting; Xu, Panpan; Chu, Wenjie; Gao, Chao; Cao, Shaodong*; Kang, Shi*Frontiers in Oncology, 2022, 12: 849626.被引 4
  • An Automated Breast Volume Scanner-Based Intra- and Peritumoral Radiomics Nomogram for the Preoperative Prediction of Expression of Ki-67 in Breast Malignancy
    Wu, Yimin*; Ma, Qianqing; Fan, Lifang; Wu, Shujian; Wang, JunliACADEMIC RADIOLOGY, 2024, 31(1): 93-103.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Clinical Breast Cancer
发表日期
2021-08
卷期
第 21 卷, 第 4 期
页码
E388-E401
DOI
10.1016/j.clbc.2020.12.004
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2017YFC1309100]; National Science Fund for Distinguished Young Scholars [81925023]; National Natural Science Foundation of China [81771912, 81701782, 81901910, 81601469, 82072090]; Guangzhou Science and Technology Project of Health [20191A011002]

作者

  • H

    Huang, Xiaomei (第一作者)

    guangdong prov peoples hosp · 2 · southern med univ

  • M

    Mai, Jinhai

查看全部 13 位作者收起作者
  • H

    Huang, Yanqi

    guangdong prov peoples hosp

  • H

    He, Lan

    guangdong prov peoples hosp

  • C

    Chen, Xin

    1

  • W

    Wu, Xiaomei

    guangdong prov peoples hosp

  • L

    Li, Yexing

    guangdong prov peoples hosp

  • Y

    Yang, Xiaojun

    guangdong prov peoples hosp

  • D

    Dong, Mengyi

    guangdong prov peoples hosp · 2 · southern med univ

  • H

    Huang, Jia

    guangdong prov peoples hosp

  • Z

    Zhang, Fang

    guangdong prov peoples hosp

  • L

    Liang, Changhong (通讯)

    2 · southern med univ · guangdong prov peoples hosp

  • L

    Liu, Zaiyi (通讯)

    guangdong prov peoples hosp · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417